Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer

Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in 24 exocrine pancreatic carcinomas, including 11 low‐passage cell lines (4–8 subcultures) and 13 uncultured samples. Aberrations were found in all cell lines and in seven of the 13 biopsies. The most frequent changes in the cell lines were gains of 20q (91%), 11q (64%), 17q (64%), 19q (64%), 8q, 12p, 14q, and 20p (55%), and losses of 18q (100%), 9p (91%), 15q (73%), 21q (64%), 3p (55%), and 13q (55%). High‐level gains (tumor to normal ratio over 1.5) were detected at 3q, 6p, 7q, 8q, 12p, 19q, and 20q. Among the tumor biopsies, overrepresentations of 7p and 8q were most common (31%), followed by 5p, 5q, 11p, 11q, 12p, and 18q (23%), whereas the most frequent losses involved 18p and 18q (31%) and 6q and 17p (23%). The genetic changes in nine samples obtained from metastatic lesions did not differ significantly from those in 15 primary carcinomas. Most of the gains and losses detected in this CGH study correspond well to those identified in previous cytogenetic and molecular genetic investigations of pancreatic carcinomas. However, frequent gain of 12p and loss of 15q have not been previously reported. Molecular genetic analyses of these chromosome arms are warranted, and may lead to the discovery of novel genes important in pancreatic carcinogenesis. Genes Chromosomes Cancer 20:383–391, 1997. © 1997 Wiley‐Liss, Inc.

[1]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Goodman,et al.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.

[3]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[4]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[5]  S. Bohlander,et al.  Consistent chromosome abnormalities in adenocarcinoma of the pancreas. , 1995, Cancer research.

[6]  Nick Bown,et al.  Comparative genomic hybridization study of primary neuroblastoma tumors , 1997, Genes, chromosomes & cancer.

[7]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[8]  F. Ajchenbaum‐Cymbalista,et al.  Overexpression of cyclin D2 in chronic B-cell malignancies. , 1995, Blood.

[9]  T. Sugimura,et al.  Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. , 1986, Japanese journal of cancer research : Gann.

[10]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Hruban,et al.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.

[12]  A. Andrén-sandberg,et al.  Cytogenetic characterization of a periampullary adenocarcinoma of the pancreas, its liver metastasis, and a cell line established from the metastasis in a patient with Gardner's syndrome , 1994 .

[13]  G. Sakorafas,et al.  Oncogenes in cancer of the pancreas. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  Y. Hayashizaki,et al.  Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. , 1996, Biochemical and biophysical research communications.

[15]  E. Schuuring.  The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. , 1995, Gene.

[16]  F. Mitelman,et al.  Variable FHIT transcripts in non‐neoplastic tissues , 1997 .

[17]  P. Marynen,et al.  Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. , 1996, Blood.

[18]  A. Klein-Szanto,et al.  Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. , 1992, Oncogene.

[19]  R. Hruban,et al.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.

[20]  C. Moskaluk,et al.  Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.

[21]  A. Andrén-sandberg,et al.  Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty‐four karyotypically unrelated clones , 1995, Genes, chromosomes & cancer.

[22]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[23]  A. Andrén-sandberg,et al.  Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: Frequent loss of 19p13.3 and gain of 19q13.1‐13.2 , 1998, Genes, chromosomes & cancer.

[24]  Y. Nakamura,et al.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. , 1993, Cancer research.

[25]  B Johansson,et al.  Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. , 1997, Cancer research.

[26]  F. Sarkar,et al.  Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. , 1996, Cancer research.

[27]  S. Elledge,et al.  Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis , 1996, Nature.

[28]  B. Johansson,et al.  Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade , 1994, International journal of cancer.

[29]  P. Carroll,et al.  Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. , 1996, Cancer research.

[30]  A. Andrén-sandberg,et al.  Karyotypic abnormalities in tumours of the pancreas. , 1993, British Journal of Cancer.

[31]  C Caldas,et al.  Allelotype of pancreatic adenocarcinoma. , 1994, Cancer research.

[32]  A. Børresen-Dale,et al.  Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. , 1996, Cancer research.

[33]  A. Horii,et al.  Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a 1‐cM region of common allelic loss , 1996, Genes, chromosomes & cancer.

[34]  P. Meltzer,et al.  Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. , 1996, Cancer research.

[35]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[36]  A. Andrén-sandberg,et al.  Nonrandom chromosomal rearrangements in pancreatic carcinomas , 1992, Cancer.

[37]  R. Hruban,et al.  Chromosome abnormalities in pancreatic adenocarcinoma , 1994, Genes, chromosomes & cancer.

[38]  A. Schäffer,et al.  Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.

[39]  J. Yager,et al.  Expression of c‐myc, c‐raf‐1, and c‐Ki‐ras in azaserine‐induced pancreatic carcinomas and growing pancreas in rats , 1990, Molecular carcinogenesis.

[40]  F. Waldman,et al.  Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma , 1997, Genes, chromosomes & cancer.

[41]  P. Lichter,et al.  Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. , 1996, Cancer research.